Incidence and management of gastrointestinal perforation from bevacizumab in advanced cancers

Taher Abu-Hejleh, James J. Mezhir, Michael J. Goodheart, Thorvardur R. Halfdanarson

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint Dive into the research topics of 'Incidence and management of gastrointestinal perforation from bevacizumab in advanced cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences